Patent 9138478 was granted and assigned to MEI Pharma on September, 2015 by the United States Patent and Trademark Office.
Novel substituted chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.